Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

mHealth-assisted expiratory muscle strength training in Parkinson's disease patients: A proof-of-concept study

M. Srp, ÁS. Ferro, J. Ferreira, R. Cacho, L. Antunes, R. Bouça-Machado, O. Gál, M. Hoskovcová, R. Kliment, J. Mužík, TA. Mestre, DP. Rangel, E. Růžička, IP. Consortium

. 2024 ; 14 (8) : 1623-1630. [pub] 20250114

Language English Country United States

Document type Journal Article, Multicenter Study

BACKGROUND: Expiratory muscle strength training (EMST) is acknowledged for its therapeutic benefits in Parkinson's disease (PD), yet long-term adherence remains a challenge. OBJECTIVE: The primary aim of this study was to assess the preliminary effects of EMST coupled with a mobile health app (SpiroGym) on self-efficacy and exercise adherence in PD patients. The secondary aim was to assess the usability of the SpiroGym app. METHODS: This single-group, multicenter, multinational proof-of-concept study involved 63 PD patients across four tertiary PD centers. Participants were enrolled in either a 1-week (n = 35) or 24-week (n = 28) EMST program coupled with SpiroGym app. Self-efficacy was assessed using the Self-Efficacy for Home Exercise Program scale (SEHEPS) and exercise adherence was monitored by SpiroGym app. Usability was evaluated using the System Usability Scale. RESULTS: Post-intervention, significant improvements in SEHEPS were observed in 1-week group (d = 0.48; p = 0.02) and 24-week group (d = 0.57; p = 0.002). Adherence rates in the 24-week PD patient group were high throughout the course of the study. Post-training SEHEPS was found to correlate (rho = 0.55; adjusted p = 0.016) with adherence to EMST during the non-supervised maintenance phase. The SpiroGym app exhibited high usability (>85th percentile score), with no significant differences noted between short-term and long-term use, indicating sustained user satisfaction. CONCLUSIONS: The results of our study suggest a promising role for SpiroGym app in supporting adherence to home-based EMST in PD patients. Nevertheless, future comparative studies are required to confirm SpiroGym's effectiveness.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010594
003      
CZ-PrNML
005      
20250429135526.0
007      
ta
008      
250415s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1877718X241296013 $2 doi
035    __
$a (PubMed)39957190
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Srp, Martin $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000322150272
245    10
$a mHealth-assisted expiratory muscle strength training in Parkinson's disease patients: A proof-of-concept study / $c M. Srp, ÁS. Ferro, J. Ferreira, R. Cacho, L. Antunes, R. Bouça-Machado, O. Gál, M. Hoskovcová, R. Kliment, J. Mužík, TA. Mestre, DP. Rangel, E. Růžička, IP. Consortium
520    9_
$a BACKGROUND: Expiratory muscle strength training (EMST) is acknowledged for its therapeutic benefits in Parkinson's disease (PD), yet long-term adherence remains a challenge. OBJECTIVE: The primary aim of this study was to assess the preliminary effects of EMST coupled with a mobile health app (SpiroGym) on self-efficacy and exercise adherence in PD patients. The secondary aim was to assess the usability of the SpiroGym app. METHODS: This single-group, multicenter, multinational proof-of-concept study involved 63 PD patients across four tertiary PD centers. Participants were enrolled in either a 1-week (n = 35) or 24-week (n = 28) EMST program coupled with SpiroGym app. Self-efficacy was assessed using the Self-Efficacy for Home Exercise Program scale (SEHEPS) and exercise adherence was monitored by SpiroGym app. Usability was evaluated using the System Usability Scale. RESULTS: Post-intervention, significant improvements in SEHEPS were observed in 1-week group (d = 0.48; p = 0.02) and 24-week group (d = 0.57; p = 0.002). Adherence rates in the 24-week PD patient group were high throughout the course of the study. Post-training SEHEPS was found to correlate (rho = 0.55; adjusted p = 0.016) with adherence to EMST during the non-supervised maintenance phase. The SpiroGym app exhibited high usability (>85th percentile score), with no significant differences noted between short-term and long-term use, indicating sustained user satisfaction. CONCLUSIONS: The results of our study suggest a promising role for SpiroGym app in supporting adherence to home-based EMST in PD patients. Nevertheless, future comparative studies are required to confirm SpiroGym's effectiveness.
650    _2
$a lidé $7 D006801
650    12
$a Parkinsonova nemoc $x rehabilitace $x patofyziologie $x terapie $7 D010300
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    _2
$a lidé středního věku $7 D008875
650    12
$a telemedicína $7 D017216
650    12
$a ověření koncepční studie $7 D000075082
650    12
$a mobilní aplikace $7 D063731
650    12
$a adherence pacienta $7 D010349
650    _2
$a sebeuplatnění $7 D020377
650    _2
$a odporový trénink $x metody $7 D055070
650    _2
$a dechová cvičení $x metody $7 D001945
650    _2
$a svalová síla $x fyziologie $7 D053580
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Ferro, Álvaro Sánchez $u HM CINAC, Hospital Universitario HM Puerta del Sur, Universidad CEU-San Pablo, Madrid, Spain $u Movement Disorders Unit, Neurology Department, Hospital Universitario 12 de Octubre, Madrid, Spain $1 https://orcid.org/0000000324612485
700    1_
$a Ferreira, Joaquim $u CNS - Campus Neurológico, Torres Vedras, Portugal $1 https://orcid.org/0000000339505113
700    1_
$a Cacho, Ricardo $u CNS - Campus Neurológico, Torres Vedras, Portugal
700    1_
$a Antunes, Laura $u CNS - Campus Neurológico, Torres Vedras, Portugal
700    1_
$a Bouça-Machado, Raquel $u CNS - Campus Neurológico, Torres Vedras, Portugal
700    1_
$a Gál, Ota $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Hoskovcová, Martina $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0009000368194104
700    1_
$a Kliment, Radim $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic $1 https://orcid.org/0000000264189434
700    1_
$a Mužík, Jan $u Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic $1 https://orcid.org/0000000248517899
700    1_
$a Mestre, Tiago A $u Parkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Institute, Ottawa, Canada
700    1_
$a Rangel, Daniel Pérez $u Movement Disorders Unit, Neurology Department, Hospital Universitario 12 de Octubre, Madrid, Spain $1 https://orcid.org/0009000796274602
700    1_
$a Růžička, Evžen $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Consortium, iCARE-Pd $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000248939661 $7 jo20000074065
773    0_
$w MED00208289 $t Journal of Parkinson's disease $x 1877-718X $g Roč. 14, č. 8 (2024), s. 1623-1630
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39957190 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135521 $b ABA008
999    __
$a ok $b bmc $g 2311773 $s 1247675
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 8 $d 1623-1630 $e 20250114 $i 1877-718X $m Journal of Parkinson's disease $n J Parkinsons Dis $x MED00208289
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...